Sight Sciences Statistics
Share Statistics
Sight Sciences has 50.75M shares outstanding. The number of shares has increased by 3.19% in one year.
Shares Outstanding | 50.75M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 1.11% |
Owned by Institutions (%) | n/a |
Shares Floating | 29.40M |
Failed to Deliver (FTD) Shares | 2.10K |
FTD / Avg. Volume | 1.03% |
Short Selling Information
The latest short interest is 1.12M, so 2.21% of the outstanding shares have been sold short.
Short Interest | 1.12M |
Short % of Shares Out | 2.21% |
Short % of Float | 3.81% |
Short Ratio (days to cover) | 7.27 |
Valuation Ratios
The PE ratio is -4.52 and the forward PE ratio is -5.22.
PE Ratio | -4.52 |
Forward PE | -5.22 |
PS Ratio | 3.1 |
Forward PS | 2 |
PB Ratio | 2.09 |
P/FCF Ratio | -5.23 |
PEG Ratio | n/a |
Enterprise Valuation
Sight Sciences Inc. has an Enterprise Value (EV) of 148.21M.
EV / Earnings | -2.67 |
EV / Sales | 1.83 |
EV / EBITDA | -3 |
EV / EBIT | -2.59 |
EV / FCF | -3.09 |
Financial Position
The company has a current ratio of 13.29, with a Debt / Equity ratio of 0.28.
Current Ratio | 13.29 |
Quick Ratio | 12.65 |
Debt / Equity | 0.28 |
Total Debt / Capitalization | 22.01 |
Cash Flow / Debt | -1.39 |
Interest Coverage | -10.59 |
Financial Efficiency
Return on equity (ROE) is -0.46% and return on capital (ROIC) is -36.87%.
Return on Equity (ROE) | -0.46% |
Return on Assets (ROA) | -0.33% |
Return on Capital (ROIC) | -36.87% |
Revenue Per Employee | 378.77K |
Profits Per Employee | -259.57K |
Employee Count | 214 |
Asset Turnover | 0.49 |
Inventory Turnover | 1.51 |
Taxes
Income Tax | 110.00K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 7.21% in the last 52 weeks. The beta is 2.73, so Sight Sciences 's price volatility has been higher than the market average.
Beta | 2.73 |
52-Week Price Change | 7.21% |
50-Day Moving Average | 4.73 |
200-Day Moving Average | 5.75 |
Relative Strength Index (RSI) | 36.8 |
Average Volume (20 Days) | 203.61K |
Income Statement
In the last 12 months, Sight Sciences had revenue of $81.06M and earned -$55.55M in profits. Earnings per share was $-1.14.
Revenue | 81.06M |
Gross Profit | 69.17M |
Operating Income | -57.27M |
Net Income | -55.55M |
EBITDA | -49.41M |
EBIT | -57.27M |
Earnings Per Share (EPS) | -1.14 |
Balance Sheet
The company has $138.13M in cash and $35.41M in debt, giving a net cash position of $102.72M.
Cash & Cash Equivalents | 138.13M |
Total Debt | 35.41M |
Net Cash | 102.72M |
Retained Earnings | -294.79M |
Total Assets | 143.60M |
Working Capital | 126.67M |
Cash Flow
In the last 12 months, operating cash flow was -$47.18M and capital expenditures -$791.00K, giving a free cash flow of -$47.98M.
Operating Cash Flow | -47.18M |
Capital Expenditures | -791.00K |
Free Cash Flow | -47.98M |
FCF Per Share | -0.99 |
Margins
Gross margin is 85.34%, with operating and profit margins of -70.66% and -68.53%.
Gross Margin | 85.34% |
Operating Margin | -70.66% |
Pretax Margin | -68.39% |
Profit Margin | -68.53% |
EBITDA Margin | -60.96% |
EBIT Margin | -70.66% |
FCF Margin | -59.19% |
Dividends & Yields
SGHT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -31.93% |
FCF Yield | -26.48% |
Analyst Forecast
The average price target for SGHT is $5.5, which is 54.1% higher than the current price. The consensus rating is "Hold".
Price Target | $5.5 |
Price Target Difference | 54.1% |
Analyst Consensus | Hold |
Analyst Count | 7 |
Scores
Altman Z-Score | -0.4 |
Piotroski F-Score | 2 |